Neurotrophins Market Developments by 2031
Neurotrophins are the neurotrophic factors that are small proteins which induce the growth, survival and function of the neurons. It regulate axon growth, dendrite pruning and protein expression that are important for basic neurological function. These proteins are secreted in nervous system at extremely low concentrations inorder to keep the nerve cells alive. Neurotrophins has been widely used for treatment of various chronic neurological disorders like Parkinson's disease, Alzheimer's disease etc. by regulating the cell death pathway. Neurotrophins induce progenitor cells differentiation to form neurons.
MARKET SCOPE
The "Global Neurotrophins Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the neurotrophins market with detailed market segmentation by product type, application, end-user, and geography. The report provides key statistics on the market status of the leading neurotrophins market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type, the global neurotrophins market is segmented into nerve growth factor, brain-derived neurotrophic factor, dehydroepiandrosterone sulfate, and other.
- On the basis of application, the market is segmented into alzheimer's disease, amyotrophic lateral sclerosis, parkinson's disease, and other.
- On the basis of end-users, the market is bifurcated into hospitals, diagnostic centers, and others.
MARKET DYNAMICS
Drivers:
- Rising prevalence of chronic neurological diseases drive the neurotrophins market.
- Growing geriatric population globally boosts the growth of neurotrophins market.
- Increasing awareness regarding mental health fuel the demand for neurotrophins market.
- Increasing research and drug development funding to various pharmaceutical industries in developed countries and growing product launch propel the growth of the market.
Restraints:
- Lack of high healthcare infrastructure in under developing countries.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The neurotrophins market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the neurotrophins market in these regions.
IMPACT OF COVID-19 ON NEUROTROPHINS MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Firstly, the COVID-19 had a negative impact on the market. With the number of rising cases, the healthcare workers have to perform alternative roles in order to meet the demand raised due to the outbreak and serve as many patients as possible. Worldwide surgeries being postponed due to the pandemic and only essentials surgeries were allowed. However, due to upliftment of imposed restrictive measure the market may witness slow and steady growth in forecast period.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The neurotrophins market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the neurotrophins market in these regions.
IMPACT OF COVID-19 ON NEUROTROPHINS MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Firstly, the COVID-19 had a negative impact on the market. With the number of rising cases, the healthcare workers have to perform alternative roles in order to meet the demand raised due to the outbreak and serve as many patients as possible. Worldwide surgeries being postponed due to the pandemic and only essentials surgeries were allowed. However, due to upliftment of imposed restrictive measure the market may witness slow and steady growth in forecast period.
MARKET PLAYERS
The report covers key developments in the neurotrophins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from neurotrophins market are anticipated to have lucrative growth opportunities in the future with the rising demand for neurotrophins in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the neurotrophins market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- R&D Systems
- Antigenix America Inc.
- Johnson?Johnson
- PeproTech
- FibroGen
- Merck Serono
- Janssen Biotech, Inc.,
- GE Healthcare
- Scil Proteins GmbH
- Lonza Groups
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neurotrophins Market - By Product Type
1.3.2 Neurotrophins Market - By Application
1.3.3 Neurotrophins Market - By End-user
1.3.4 Neurotrophins Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEUROTROPHINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. NEUROTROPHINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEUROTROPHINS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROTROPHINS - GLOBAL MARKET OVERVIEW
6.2. NEUROTROPHINS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NEUROTROPHINS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. NERVE GROWTH FACTOR
7.3.1. Overview
7.3.2. Nerve Growth Factor Market Forecast and Analysis
7.4. BRAIN-DERIVED NEUROTROPHIC FACTOR
7.4.1. Overview
7.4.2. Brain-Derived Neurotrophic Factor Market Forecast and Analysis
7.5. DEHYDROEPIANDROSTERONE SULFATE
7.5.1. Overview
7.5.2. Dehydroepiandrosterone Sulfate Market Forecast and Analysis
7.6. OTHER
7.6.1. Overview
7.6.2. Other Market Forecast and Analysis
8. NEUROTROPHINS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ALZHEIMER'S DISEASE
8.3.1. Overview
8.3.2. Alzheimer's Disease Market Forecast and Analysis
8.4. AMYOTROPHIC LATERAL SCLEROSIS
8.4.1. Overview
8.4.2. Amyotrophic Lateral Sclerosis Market Forecast and Analysis
8.5. PARKINSON'S DISEASE
8.5.1. Overview
8.5.2. Parkinson's Disease Market Forecast and Analysis
8.6. OTHER
8.6.1. Overview
8.6.2. Other Market Forecast and Analysis
9. NEUROTROPHINS MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. NEUROTROPHINS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Neurotrophins Market Overview
10.1.2 North America Neurotrophins Market Forecasts and Analysis
10.1.3 North America Neurotrophins Market Forecasts and Analysis - By Product Type
10.1.4 North America Neurotrophins Market Forecasts and Analysis - By Application
10.1.5 North America Neurotrophins Market Forecasts and Analysis - By End-user
10.1.6 North America Neurotrophins Market Forecasts and Analysis - By Countries
10.1.6.1 Canada Neurotrophins Market
10.1.6.1.1 Canada Neurotrophins Market by Product Type
10.1.6.1.2 Canada Neurotrophins Market by Application
10.1.6.1.3 Canada Neurotrophins Market by End-user
10.1.6.2 Mexico Neurotrophins Market
10.1.6.2.1 Mexico Neurotrophins Market by Product Type
10.1.6.2.2 Mexico Neurotrophins Market by Application
10.1.6.2.3 Mexico Neurotrophins Market by End-user
10.1.6.3 US Neurotrophins Market
10.1.6.3.1 US Neurotrophins Market by Product Type
10.1.6.3.2 US Neurotrophins Market by Application
10.1.6.3.3 US Neurotrophins Market by End-user
10.2. EUROPE
10.2.1 Europe Neurotrophins Market Overview
10.2.2 Europe Neurotrophins Market Forecasts and Analysis
10.2.3 Europe Neurotrophins Market Forecasts and Analysis - By Product Type
10.2.4 Europe Neurotrophins Market Forecasts and Analysis - By Application
10.2.5 Europe Neurotrophins Market Forecasts and Analysis - By End-user
10.2.6 Europe Neurotrophins Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Neurotrophins Market
10.2.6.1.1 Germany Neurotrophins Market by Product Type
10.2.6.1.2 Germany Neurotrophins Market by Application
10.2.6.1.3 Germany Neurotrophins Market by End-user
10.2.6.2 France Neurotrophins Market
10.2.6.2.1 France Neurotrophins Market by Product Type
10.2.6.2.2 France Neurotrophins Market by Application
10.2.6.2.3 France Neurotrophins Market by End-user
10.2.6.3 Italy Neurotrophins Market
10.2.6.3.1 Italy Neurotrophins Market by Product Type
10.2.6.3.2 Italy Neurotrophins Market by Application
10.2.6.3.3 Italy Neurotrophins Market by End-user
10.2.6.4 Spain Neurotrophins Market
10.2.6.4.1 Spain Neurotrophins Market by Product Type
10.2.6.4.2 Spain Neurotrophins Market by Application
10.2.6.4.3 Spain Neurotrophins Market by End-user
10.2.6.5 United Kingdom Neurotrophins Market
10.2.6.5.1 United Kingdom Neurotrophins Market by Product Type
10.2.6.5.2 United Kingdom Neurotrophins Market by Application
10.2.6.5.3 United Kingdom Neurotrophins Market by End-user
10.2.6.6 Rest of Europe Neurotrophins Market
10.2.6.6.1 Rest of Europe Neurotrophins Market by Product Type
10.2.6.6.2 Rest of Europe Neurotrophins Market by Application
10.2.6.6.3 Rest of Europe Neurotrophins Market by End-user
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Neurotrophins Market Overview
10.3.2 Asia-Pacific Neurotrophins Market Forecasts and Analysis
10.3.3 Asia-Pacific Neurotrophins Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Neurotrophins Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Neurotrophins Market Forecasts and Analysis - By End-user
10.3.6 Asia-Pacific Neurotrophins Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Neurotrophins Market
10.3.6.1.1 Australia Neurotrophins Market by Product Type
10.3.6.1.2 Australia Neurotrophins Market by Application
10.3.6.1.3 Australia Neurotrophins Market by End-user
10.3.6.2 China Neurotrophins Market
10.3.6.2.1 China Neurotrophins Market by Product Type
10.3.6.2.2 China Neurotrophins Market by Application
10.3.6.2.3 China Neurotrophins Market by End-user
10.3.6.3 India Neurotrophins Market
10.3.6.3.1 India Neurotrophins Market by Product Type
10.3.6.3.2 India Neurotrophins Market by Application
10.3.6.3.3 India Neurotrophins Market by End-user
10.3.6.4 Japan Neurotrophins Market
10.3.6.4.1 Japan Neurotrophins Market by Product Type
10.3.6.4.2 Japan Neurotrophins Market by Application
10.3.6.4.3 Japan Neurotrophins Market by End-user
10.3.6.5 South Korea Neurotrophins Market
10.3.6.5.1 South Korea Neurotrophins Market by Product Type
10.3.6.5.2 South Korea Neurotrophins Market by Application
10.3.6.5.3 South Korea Neurotrophins Market by End-user
10.3.6.6 Rest of Asia-Pacific Neurotrophins Market
10.3.6.6.1 Rest of Asia-Pacific Neurotrophins Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Neurotrophins Market by Application
10.3.6.6.3 Rest of Asia-Pacific Neurotrophins Market by End-user
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Neurotrophins Market Overview
10.4.2 Middle East and Africa Neurotrophins Market Forecasts and Analysis
10.4.3 Middle East and Africa Neurotrophins Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Neurotrophins Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Neurotrophins Market Forecasts and Analysis - By End-user
10.4.6 Middle East and Africa Neurotrophins Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Neurotrophins Market
10.4.6.1.1 South Africa Neurotrophins Market by Product Type
10.4.6.1.2 South Africa Neurotrophins Market by Application
10.4.6.1.3 South Africa Neurotrophins Market by End-user
10.4.6.2 Saudi Arabia Neurotrophins Market
10.4.6.2.1 Saudi Arabia Neurotrophins Market by Product Type
10.4.6.2.2 Saudi Arabia Neurotrophins Market by Application
10.4.6.2.3 Saudi Arabia Neurotrophins Market by End-user
10.4.6.3 U.A.E Neurotrophins Market
10.4.6.3.1 U.A.E Neurotrophins Market by Product Type
10.4.6.3.2 U.A.E Neurotrophins Market by Application
10.4.6.3.3 U.A.E Neurotrophins Market by End-user
10.4.6.4 Rest of Middle East and Africa Neurotrophins Market
10.4.6.4.1 Rest of Middle East and Africa Neurotrophins Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Neurotrophins Market by Application
10.4.6.4.3 Rest of Middle East and Africa Neurotrophins Market by End-user
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Neurotrophins Market Overview
10.5.2 South and Central America Neurotrophins Market Forecasts and Analysis
10.5.3 South and Central America Neurotrophins Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Neurotrophins Market Forecasts and Analysis - By Application
10.5.5 South and Central America Neurotrophins Market Forecasts and Analysis - By End-user
10.5.6 South and Central America Neurotrophins Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Neurotrophins Market
10.5.6.1.1 Brazil Neurotrophins Market by Product Type
10.5.6.1.2 Brazil Neurotrophins Market by Application
10.5.6.1.3 Brazil Neurotrophins Market by End-user
10.5.6.2 Argentina Neurotrophins Market
10.5.6.2.1 Argentina Neurotrophins Market by Product Type
10.5.6.2.2 Argentina Neurotrophins Market by Application
10.5.6.2.3 Argentina Neurotrophins Market by End-user
10.5.6.3 Rest of South and Central America Neurotrophins Market
10.5.6.3.1 Rest of South and Central America Neurotrophins Market by Product Type
10.5.6.3.2 Rest of South and Central America Neurotrophins Market by Application
10.5.6.3.3 Rest of South and Central America Neurotrophins Market by End-user
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEUROTROPHINS MARKET, KEY COMPANY PROFILES
12.1. R AND D SYSTEMS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ANTIGENIX AMERICA INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. JOHNSON AND JOHNSON
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PEPROTECH
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. FIBROGEN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK SERONO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JANSSEN BIOTECH, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GE HEALTHCARE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SCIL PROTEINS GMBH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LONZA GROUPS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. R and D Systems
2. Antigenix America Inc.
3. Johnson and Johnson
4. PeproTech
5. FibroGen
6. Merck Serono
7. Janssen Biotech, Inc.
8. GE Healthcare
9. Scil Proteins GmbH
10. Lonza Groups
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For